About LIMM

The Leeds Institute of Molecular Medicine (LIMM) is dedicated to research into defining the molecules involved in human diseases and in translational research to convert these studies into novel therapies. Our research in LIMM is carried out by both basic and clinical scientists. There are currently thirteen Sections arranged in four Divisions studying the spectrum of human disease and incorporating a Clinical Trials Section providing a persuasive basis for our bench to bedside scientific strategy and furthermore facilitating a bedside to bench approach by permitting clinical sample availability and directly facilitating clinical interactions mediated through our clinical research workers in LIMM.

Part of LIMM is housed in a new building on the St James’s site known as the Wellcome Trust Brenner Building, which was officially opened in May 2007 by Dr Sydney Brenner FRS CH, Nobel Laureate in Medicine (2002). The Wellcome Trust Brenner Building adds to existing LIMM facilities in the Clinical Sciences Building and the Cancer Research Building at the St James’s site.

We take a multi-disciplinary approach to research into human disease in LIMM and this will allow us to be at the international forefront in defining the molecular events underlying human disease aetiology and in designing and implementing new therapies for diseases in the fields of cancer, rheumatology and inherited syndromes. Research initiatives include the YCR Centre for Pre-Cancer Genomics, the NIHR Leeds Musculoskeletal Biomedical Research Unit and the LIMM Chemical Cancer Biology Programme in the Section of Experimental Therapeutics. These will provide the basis to recruit new world-class research scientists to enhance and further our mission to facilitate improvements in human healthcare.

LIMM Organisation
Professor Peter Selby	Director
Mrs Janet Holt	Director of Administration

Divisions
Division of Applied Clinical Research Paul Emery Phil Hopkins	Head: Paul Emery Section of Musculoskeletal Disease Section of Translational Anaesthetic & Surgical Sciences
Division of Molecular & Translational Medicine David Bonthron Mark Hull Chris Inglehearn Alex Markham	Head: Alex Markham Section of Genetics Section of Molecular Gastroenterology Section of Ophthalmology & Neuroscience Section of Translational Medicine
Division of Oncology, Epidemiology & Clinical Research Tim Bishop Julia Brown Margaret Knowles Peter Selby	Head: Tim Bishop Section of Epidemiology & Biostatistics Section of Clinical Trials Research Section of Experimental Oncology Section of Oncology & Clinical Research
Division of Cancer & Developmental Biology Constanze Bonifer Phil Quirke Terence Rabbitts	Head: Phil Quirke Section of Experimental Haematology Section of Pathology & Tumour Biology Section of Experimental Therapeutics